Abstract
The effect of lysine-8-vasopressin (300 mU/kg b.w.) has been tested in a single-trial step-down passive avoidance test. Vasopressin treatment resulted in an improvement of step-down latency in normal rats, but this action disappeared when the animals were pretreated with 80 mg/kg alpha-methyl- p-tyrosine (α-MT). Vasopressin treatment decreased the hypothalamic, septal and striatal dopamine (DA) levels. Following vasopressin, the turnover of norepinephrine (NE) increased in the hypothalamus, as did these of DA in the septum and striatum. The data suggest that the cerebral catecholaminergic system might be one of the important mediators of the behavioural action of vasopressin.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
